C3.
| Revenue (TTM) | $250.27M |
| Gross Profit (TTM) | $77.38M |
| EBITDA | $-474.32M |
| Operating Margin | -213.80% |
| Return on Equity | -63.00% |
| Return on Assets | -33.10% |
| Revenue/Share (TTM) | $1.78 |
| Book Value | $4.42 |
| Price-to-Book | 2.36 |
| Price-to-Sales (TTM) | 6.03 |
| EV/Revenue | 3.891 |
| EV/EBITDA | -2.30 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -52.50% |
| Shares Outstanding | $151.95M |
| Float | $138.94M |
| % Insiders | 4.90% |
| % Institutions | 66.47% |
Volatility is currently expanding
SAN FRANCISCO & NEW YORK--(BUSINESS WIRE)---- $AI #AI--Longevica names former Genentech/Roche executive Dr. Prasun Mishra CEO to advance its $13M mammalian longevity study toward IND-enabling development.
C3.ai, Inc. (AI) reached $9.7 at the closing of the latest trading day, reflecting a -2.32% change compared to its last close.
C3.ai (NYSE:AI | AI Price Prediction) currently trades at $10.18, while Wedbush Securities analyst Dan Ives carries a Street-high price target of $15 on the enterprise AI software company, implying roughly 47% upside from here.
C3.ai specializes in industry-specific agentic AI applications designed for massive industrial and government organizations. CrowdStrike dominates the cloud-native cybersecurity market with its Falcon platform and expanding ecosystem of security partners.
Agentic AI software names are moving together this Friday afternoon, and the leaderboard looks like a mirror image of Monday's session.
Aehr Test Systems provides essential wafer-level testing for high-growth sectors like silicon carbide and silicon photonics. C3.ai is transitioning its enterprise software platform toward a consumption-based pricing model to drive broader adoption.
C3.ai (AI) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Nebius Group N.V. NBIS and C3.ai, Inc. AI are capitalizing on the rapid adoption of AI, but they are pursuing distinct growth strategies to capture the expanding market opportunity.
C3.ai is positioned as a distressed, event-driven turnaround with a base case fair value of $10, ~12% above current levels. Federal segment bookings are compounding rapidly, the partner pipeline is strong, and expenses have been restructured, providing a credible path to stabilization. The thesis hinges on gross margin recovery, sustained federal growth, and flat opex, with Q1 FY2027 as the critical catalyst for validation.
In the closing of the recent trading day, C3.ai, Inc. (AI) stood at $8.91, denoting a -2.52% move from the preceding trading day.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AI and any ticker you trade — then tracks every position and per-strategy win rate.
